SEARCH

SEARCH BY CITATION

References

  • Albano, F., Mestice, A., Pannunzio, A., Lanza, F., Martino, B., Pastore, D., Ferrara, F., Carluccio, P., Nobile, F., Castoldi, G., Liso, V. & Specchia, G. (2006) The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica, 91, 311316.
  • Alimoghaddam, K., Ghavamzadeh, A. & Jahani, M. (2006) Use of Novoseven for arsenic trioxide-induced bleeding in PML. American Journal of Hematology, 81, 720.
  • Ardoin, S.P., Shanahan, J.C. & Pisetsky, D.S. (2007) The role of microparticles in inflammation and thrombosis. Scandinavian Journal of Immunology, 66, 159165.
  • Arnould, C., Philippe, C., Bourdon, V., Gr goire, M.J., Berger, R. & Jonveaux, P. (1999) The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Human Molecular Genetics, 8, 17411749.
  • Avvisati, G., ten Cate, J.W., Sturk, A., Lamping, R., Petti, M.G. & Mandelli, F. (1988) Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia. British Journal of Haematology, 70, 4348.
  • Avvisati, G., ten Cate, J.W., Buller, H.R. & Mandelli, F. (1989) Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet, 2, 122124.
  • Avvisati, G., Petti, M.C., Lo-Coco, F., Vegna, M.L., Amadori, S., Baccarani, M., Cantore, N., Di Bona, E., Ferrara, F., Fioritoni, G., Gallo, E., Invernizzi, R., Lazzarino, M., Liso, V., Mariani, G., Ricciuti, F., Selleri, C., Sica, S., Veneri, D. & Mandelli, F. (2002) Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood, 100, 31413146.
  • Barbui, T., Finazzi, G. & Falanga, A. (1998) The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood, 91, 30933102.
  • Bauer, K.A. & Rosenberg, R.D. (1984) Thrombin generation in acute promyelocytic leukemia. Blood, 64, 791796.
  • Baysan, A., Yel, L., Gollapudi, S., Su, H. & Gupta, S. (2007) Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells. International Journal of Oncology, 30, 313318.
  • Bell, S.F., Rayment, R., Collins, P.W. & Collis, R.E. (2010) The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. International Journal of Obstetric Anesthesia, 19, 218223.
  • Bennett, B., Booth, N.A., Croll, A. & Dawson, A.A. (1989) The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. British Journal of Haematology, 71, 511517.
  • Biondi, A., Luciano, A., Bassan, R., Mininni, D., Specchia, G., Lanzi, E., Castagna, S., Cantu-Rajnoldi, A., Liso, V. & Masera, G. (1995) CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia, 9, 14611466.
  • Breccia, M., Avvisati, G., Latagliata, R., Carmosino, I., Guarini, A., De Propris, M.S., Gentilini, F., Petti, M.C., Cimino, G., Mandelli, F. & Lo-Coco, F. (2007) Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia, 21, 7983.
  • British Committee for Standards in Haematology Transfusion Task Force (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 1023.
  • Brown, J.E., Olujohungbe, A., Chang, J., Ryder, W.D., Morganstern, G.R., Chopra, R. & Scarffe, J.H. (2000) All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia. British Journal of Haematology, 110, 10101012.
  • Cahill, T.J., Chowdhury, O., Myerson, S.G., Ormerod, O., Herring, N., Grimwade, D., Littlewood, T. & Peniket, A. (2011) Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging. Circulation, 123, e370e372.
  • Cesarman, G.M., Guevara, C.A. & Hajjar, K.A. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. The Journal of Biological Chemistry, 269, 2119821203.
  • Chen, S.J., Zelent, A., Tong, J.H., Yu, H.Q., Wang, Z.Y., Derre, J., Berger, R., Waxman, S. & Chen, Z. (1993) Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. Journal of Clinical Investigation, 91, 22602267.
  • Chuecas, F., Loredo, E., Munoz, B., Alfaro, J., Grebe, G. & Lira, P. (1991) Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters. Revista Medica de Chile, 119, 984989.
  • Claxton, D.F., Reading, C.L., Nagarajan, L., Tsujimoto, Y., Andersson, B.S., Estey, E., Cork, A., Huh, Y.O., Trujillo, J. & Deisseroth, A.B. (1992) Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood, 80, 582586.
  • Cordonnier, C., Vernant, J.P., Brun, B., Heilmann, M.G., Kuentz, M., Bierling, P., Farcet, J.P., Rodet, M., Duedari, N. & Imbert, M. (1985) Acute promyelocytic leukemia in 57 previously untreated patients. Cancer, 55, 1825.
  • Cunningham, I., Gee, T.S., Reich, L.M., Kempin, S.J., Naval, A.N. & Clarkson, B.D. (1989) Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood, 73, 11161122.
  • Dally, N., Hoffman, R., Haddad, N., Sarig, G., Rowe, J.M. & Brenner, B. (2005) Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. Thrombosis Research, 116, 109114.
  • Das, R., Burke, T. & Plow, E.F. (2007) Histone H2B as a functionally important plasminogen receptor on macrophages. Blood, 110, 37633772.
  • Dassah, M., Deora, A.B., He, K. & Hajjar, K.A. (2009) The endothelial cell annexin A2 system and vascular fibrinolysis. General Physiology and Biophysics, 28 Spec No Focus, F20F28.
  • De Stefano, V., Sora, F., Rossi, E., Chiusolo, P., Laurenti, L., Fianchi, L., Zini, G., Pagano, L., Sica, S. & Leone, G. (2005) The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. Journal of Thrombosis and Haemostasis, 3, 19851992.
  • Di Bona, E., Avvisati, G., Castaman, G., Luce Vegna, M., De Sanctis, V., Rodeghiero, F. & Mandelli, F. (2000) Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. British Journal of Haematology, 108, 689695.
  • Didisheim, P., Trombold, J.S., Vandervoort, L.E. & Mibashan, R.S. (1964) Acute promyelocytic leukemia with fibrinogen and factor V deficiencies. Blood, 23, 717728.
  • Dittman, W.A. & Majerus, P.W. (1990) Structure and function of thrombomodulin: a natural anticoagulant. Blood, 75, 329336.
  • Dombret, H., Scrobohaci, M.L., Ghorra, P., Zini, J.M., Daniel, M.T., Castaigne, S. & Degos, L. (1993) Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia, 7, 29.
  • Dombret, H., Scrobohaci, M.L., Daniel, M.T., Micléa, J.M., Castaigne, S., Chomienne, C., Fenaux, P. & Degos, L. (1995) In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy. Leukemia, 9, 1924.
  • Dubois, C., Schlageter, M.H., de Gentile, A., Balitrand, N., Toubert, M.E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y., Degos, L., Chomienne, C. & Balitrand, N. (1994) Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia, 8, 17501757.
  • Escudier, S.M., Kantarjian, H.M. & Estey, E.H. (1996) Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leukaemia & Lymphoma, 20, 435439.
  • Estey, E., Thall, P.F., Pierce, S., Kantarjian, H. & Keating, M. (1997) Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. Journal of Clinical Oncology, 15, 483490.
  • Evans, G.D. & Grimwade, D.J. (1999) Extramedullary disease in acute promyelocytic leukemia. Leukaemia & Lymphoma, 33, 219229.
  • Falanga, A., Alessio, M.G., Donati, M.B. & Barbui, T. (1988) A new procoagulant in acute leukemia. Blood, 71, 870875.
  • Falanga, A., Consonni, R., Marchetti, M., Mielicki, W.P., Rambaldi, A., Lanotte, M., Gordon, S.G. & Barbui, T. (1994) Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid. Leukemia, 8, 156159.
  • Falanga, A., Iacoviello, L., Evangelista, V., Belotti, D., Consonni, R., D’Orazio, A., Robba, L., Donati, M.B. & Barbui, T. (1995) Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood, 86, 10721081.
  • Falanga, A., Consonni, R., Marchetti, M., Locatelli, G., Garattini, E., Passerini, C.G., Gordon, S.G. & Barbui, T. (1998) Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood, 92, 143151.
  • Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T., Bowen, D. et al (1993) Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood, 82, 32413249.
  • Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood, 94, 11921200.
  • Fergusson, D.A., Hebert, P.C., Mazer, C.D., Fremes, S., MacAdams, C., Murkin, J.M., Teoh, K., Duke, P.C., Arellano, R., Blajchman, M.A., Bussieres, J.S., Cote, D., Karski, J., Martineau, R., Robblee, J.A., Rodger, M., Wells, G., Clinch, J. & Pretorius, R. (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine, 358, 23192331.
  • Gale, R.E., Hills, R., Pizzey, A.R., Kottaridis, P.D., Swirsky, D., Gilkes, A.F., Nugent, E., Mills, K.I., Wheatley, K., Solomon, E., Burnett, A.K., Linch, D.C. & Grimwade, D. (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood, 106, 37683776.
  • Graf, M., Reif, S., Hecht, K., Pelka-Fleischer, R., Pfister, K. & Schmetzer, H. (2005) High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. American Journal of Hematology, 79, 2635.
  • Griffin, J.D., Rambaldi, A., Vellenga, E., Young, D.C., Ostapovicz, D. & Cannistra, S.A. (1987) Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood, 70, 12181221.
  • Grimwade, D., Biondi, A., Mozziconacci, M.J., Hagemeijer, A., Berger, R., Neat, M., Howe, K., Dastugue, N., Jansen, J., Radford-Weiss, I., Lo Coco, F., Lessard, M., Hernandez, J.M., Delabesse, E., Head, D., Liso, V., Sainty, D., Flandrin, G., Solomon, E., Birg, F. & Lafage-Pochitaloff, M. (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d’Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action “Molecular Cytogenetic Diagnosis in Haematological Malignancies”. Blood, 96, 12971308.
  • Grimwade, D., Mistry, A.R., Solomon, E. & Guidez, F. (2009a) Acute promyelocytic leukemia: a paradigm for differentiation therapy. Cancer Treatment and Research, 145, 219235.
  • Grimwade, D., Jovanovic, J.V., Hills, R.K., Nugent, E.A., Patel, Y., Flora, R., Diverio, D., Jones, K., Aslett, H., Batson, E., Rennie, K., Angell, R., Clark, R.E., Solomon, E., Lo-Coco, F., Wheatley, K. & Burnett, A.K. (2009b) Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. Journal of Clinical Oncology, 27, 36503658.
  • Groopman, J. & Ellman, L. (1979) Acute promyelocytic leukemia. American Journal of Hematology, 7, 395408.
  • Hajjar, K.A. & Acharya, S.S. (2000) Annexin II and regulation of cell surface fibrinolysis. Annals of the New York Academy of Sciences, 902, 265271.
  • Hajjar, K.A., Jacovina, A.T. & Chacko, J. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. The Journal of Biological Chemistry, 269, 2119121197.
  • Hill, J. & Treasure, T. (2010) Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart, 96, 879882.
  • Hoke, S.R. & Trent, J.L. (1976) Letter: non-effect of heparin on serum electrolyte values. Clinical Chemistry, 22, 1540.
  • Imaoka, S., Ueda, T., Shibata, H., Masaoka, T., Ogawa, M., Sasaki, Y., Iwanaga, T. & Terasawa, T. (1986) Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy. Cancer, 58, 17361738.
  • Jetha, N. (1981) Promyelocytic leukemia with multiorgan infarctions and large-vessel thrombosis. Archives of Pathology and Laboratory Medicine, 105, 683684.
  • Kawai, Y., Watanabe, K., Kizaki, M., Murata, M., Kamata, T., Uchida, H., Moriki, T., Yokoyama, K., Tokuhira, M., Nakajima, H. et al (1994) Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia. American Journal of Hematology, 46, 184188.
  • Keane, T.J., Gorman, A.M., O’ Connell, L.G. & Fennelly, J.J. (1976) epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia. Acta Haematologica, 56, 202204.
  • Khalil, N., Corne, S., Whitman, C. & Yacyshyn, H. (1996) Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. American Journal of Respiratory Cell and Molecular Biology, 15, 252259.
  • Khan, M.M., Liu, Y., Khan, M.E., Gilman, M.L., Khan, S.T., Bromberg, M. & Colman, R.W. (2010) Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. American Journal of Physiology. Heart and Circulatory Physiology, 298, H652H658.
  • Koyama, T., Hirosawa, S., Kawamata, N., Tohda, S. & Aoki, N. (1994) All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood, 84, 30013009.
  • Kuchenbauer, F., Schoch, C., Kern, W., Hiddemann, W., Haferlach, T. & Schnittger, S. (2005) Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia. British Journal of Haematology, 130, 196202.
  • Kwaan, H.C. & Magalhaes Rego, E. (2010) Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Seminars in Thrombosis and Hemostasis, 36, 917924.
  • Kwaan, H.C., Wang, J. & Boggio, L.N. (2002) Abnormalities in hemostasis in acute promyelocytic leukemia. Hematological Oncology, 20, 3341.
  • Kwaan, H.C., Wang, J. & Weiss, I. (2004) Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin. Journal of Thrombosis and Haemostasis, 2, 306312.
  • Langer, F., Spath, B., Haubold, K., Holstein, K., Marx, G., Wierecky, J., Brummendorf, T.H., Dierlamm, J., Bokemeyer, C. & Eifrig, B. (2008) Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Annals of Hematology, 87, 451457.
  • Lehmann, S., Ravn, A., Carlsson, L., Antunovic, P., Deneberg, S., Mollgard, L., Derolf, A.R., Stockelberg, D., Tidefelt, U., Wahlin, A., Wennstrom, L., Hoglund, M. & Juliusson, G. (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia, 25, 11281134.
  • Levi, M. (2004) Current understanding of disseminated intravascular coagulation. British Journal of Haematology, 124, 567576.
  • Levin, M.D., Betjes, M.G., VdK, T.H., Wenberg, B.L. & Leebeek, F.W. (2003) Acute renal cortex necrosis caused by arterial thrombosis during treatment for acute promyelocytic leukemia. Haematologica, 88, ECR21.
  • Liu, Y.J., Wu, D.P., Liang, J.Y., Qiu, H.Y., Jin, Z.M., Tang, X.W., Fu, C.C. & Ma, X. (2010) Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients. Medical Oncology, 10.1007/s12032-010-9733-7 .
  • Liu, Y., Wang, Z., Jiang, M., Dai, L., Zhang, W., Wu, D. & Ruan, C. (2011) The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leukemia Research, 35, 879884.
  • Luesink, M., Pennings, J.L., Wissink, W.M., Linssen, P.C., Muus, P., Pfundt, R., de Witte, T.J., van der Reijden, B.A. & Jansen, J.H. (2009) Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood, 114, 55125521.
  • Madoiwa, S., Tanaka, H., Nagahama, Y., Dokai, M., Kashiwakura, Y., Ishiwata, A., Sakata, A., Yasumoto, A., Ohmori, T., Mimuro, J. & Sakata, Y. (2011) Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation. Thrombosis Research, 127, 349355.
  • Mahendra, P., Keeling, D.M., Hood, I.M., Baglin, T.P. & Marcus, R.E. (1996) Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin. Clinical & Laboratory Haematology, 18, 5152.
  • Mantovani, A., Bussolino, F. & Dejana, E. (1992) Cytokine regulation of endothelial cell function. FASEB Journal, 6, 25912599.
  • Matsuda, T., Asakura, H., Ito, K., Saito, M., Jokaji, Y., Uotani, C. & Kumabashiri, I. (1988) Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC. Thrombosis Research. Supplement, 8, 143151.
  • Menell, J.S., Cesarman, G.M., Jacovina, A.T., McLaughlin, M.A., Lev, E.A. & Hajjar, K.A. (1999) Annexin II and bleeding in acute promyelocytic leukemia. New England Journal of Medicine, 340, 9941004.
  • Milligan, D.W., Grimwade, D., Cullis, J.O., Bond, L., Swirsky, D., Craddock, C., Kell, J., Homewood, J., Campbell, K., McGinley, S., Wheatley, K. & Jackson, G. (2006) Guidelines on the management of acute myeloid leukaemia in adults. British Journal of Haematology, 135, 450474.
  • Mondino, A. & Blasi, F. (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends in Immunology, 25, 450455.
  • Montesinos, P., Diaz-Mediavilla, J., Deben, G., Prates, V., Tormo, M., Rubio, V., Perez, I., Fernandez, I., Viguria, M., Rayon, C., Gonzalez, J., de la Serna, J., Esteve, J., Bergua, J.M., Rivas, C., Gonzalez, M., Gonzalez, J.D., Negri, S., Brunet, S., Lowenberg, B. & Sanz, M.A. (2009) Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica, 94, 12421249.
  • Oudijk, E.J., Nieuwenhuis, H.K., Bos, R. & Fijnheer, R. (2000) Elastase mediated fibrinolysis in acute promyelocytic leukemia. Thrombosis and Haemostasis, 83, 906908.
  • Park, J.H., Qiao, B., Panageas, K.S., Schymura, M.J., Jurcic, J.G., Rosenblat, T.L., Altman, J.K., Douer, D., Rowe, J.M. & Tallman, M.S. (2011) Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood, 118, 12481254.
  • Pisciotto, P.T., Benson, K., Hume, H., Glassman, A.B., Oberman, H., Popovsky, M., Hines, D. & Anderson, K. (1995) Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion, 35, 498502.
  • Polliack, A. (1971) Acute promyelocytic leukemia with disseminated intravascular coagulation. American Journal of Clinical Pathology, 56, 155161.
  • Redner, R.L., Rush, E.A., Faas, S., Rudert, W.A. & Corey, S.J. (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood, 87, 882886.
  • Rodeghiero, F., Avvisati, G., Castaman, G., Barbui, T. & Mandelli, F. (1990) Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood, 75, 21122117.
  • Sakata, Y., Murakami, T., Noro, A., Mori, K. & Matsuda, M. (1991) The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood, 77, 19491957.
  • Sanz, M.A., Martin, G., Rayon, C., Esteve, J., Gonzalez, M., Diaz-Mediavilla, J., Bolufer, P., Barragan, E., Terol, M.J., Gonzalez, J.D., Colomer, D., Chillon, C., Rivas, C., Gomez, T., Ribera, J.M., Bornstein, R., Roman, J., Calasanz, M.J., Arias, J., Alvarez, C., Ramos, F. & Deben, G. (1999) A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood, 94, 30153021.
  • Sanz, M.A., Martin, G., Gonzalez, M., Leon, A., Rayon, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., Serna De La, J., Roman, J., Barragan, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J. & Bolufer, P. (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood, 103, 12371243.
  • Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Buchner, T., Dohner, H., Burnett, A.K. & Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113, 18751891.
  • Schochl, H., Nienaber, U., Hofer, G., Voelckel, W., Jambor, C., Scharbert, G., Kozek-Langenecker, S. & Solomon, C. (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care, 14, R55.
  • de la Serna, J., Montesinos, P., Vellenga, E., Rayon, C., Parody, R., Leon, A., Esteve, J., Bergua, J.M., Milone, G., Deben, G., Rivas, C., Gonzalez, M., Tormo, M., Diaz-Mediavilla, J., Gonzalez, J.D., Negri, S., Amutio, E., Brunet, S., Lowenberg, B. & Sanz, M.A. (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood, 111, 33953402.
  • Shakur, H., Roberts, I., Bautista, R., Caballero, J., Coats, T., Dewan, Y., El-Sayed, H., Gogichaishvili, T., Gupta, S., Herrera, J., Hunt, B., Iribhogbe, P., Izurieta, M., Khamis, H., Komolafe, E., Marrero, M.A., Mejia-Mantilla, J., Miranda, J., Morales, C., Olaomi, O., Olldashi, F., Perel, P., Peto, R., Ramana, P.V., Ravi, R.R. & Yutthakasemsunt, S. (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 376, 2332.
  • Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., Chen, Y., Shen, Y., Wu, W., Tang, W., Waxman, S., De The, H., Wang, Z.Y., Chen, S.J. & Chen, Z. (2004) All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 101, 53285335.
  • Stein, E., McMahon, B., Kwaan, H., Altman, J.K., Frankfurt, O. & Tallman, M.S. (2009) The coagulopathy of acute promyelocytic leukaemia revisited. Best Practice and Research. Clinical Haematology, 22, 153163.
  • Sureda, A., Garcia Frade, L.J., Torrado, M.C., Garcia Larana, J. & Garcia Avello, A. (1992) A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia. Acta Haematologica, 88, 100104.
  • Syrovets, T., Tippler, B., Rieks, M. & Simmet, T. (1997) Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood, 89, 45744583.
  • Takahashi, H., Tatewaki, W., Wada, K., Hanano, M. & Shibata, A. (1990) Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. American Journal of Hematology, 33, 9095.
  • Tallman, M.S. & Kwaan, H.C. (1992) Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood, 79, 543553.
  • Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 10211028.
  • Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Woods, W.G., Ogden, A., Weinstein, H., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (2002) All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 100, 42984302.
  • Tallman, M.S., Lefebvre, P., Baine, R.M., Shoji, M., Cohen, I., Green, D., Kwaan, H.C., Paietta, E. & Rickles, F.R. (2004) Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Journal of Thrombosis and Haemostasis, 2, 13411350.
  • Tallman, M.S., Brenner, B., Serna Jde, L., Dombret, H., Falanga, A., Kwaan, H.C., Liebman, H., Raffoux, E. & Rickles, F.R. (2005) Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. Leukemia Research, 29, 347351.
  • de The, H. & Chen, Z. (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nature Reviews Cancer, 10, 775783.
  • Wang, J., Weiss, I., Svoboda, K. & Kwaan, H.C. (2001) Thrombogenic role of cells undergoing apoptosis. British Journal of Haematology, 115, 382391.
  • Wassenaar, T., Black, J., Kahl, B., Schwartz, B., Longo, W., Mosher, D. & Williams, E. (2008) Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. Hematological Oncology, 26, 241246.
  • Wells, R.A., Catzavelos, C. & Kamel-Reid, S. (1997) Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nature Genetics, 17, 109113.
  • Wilde, J.T. & Davies, J.M. (1990) Haemostatic problems in acute leukaemia. Blood Reviews, 4, 245251.
  • Yan, J., Wang, K., Dong, L., Liu, H., Chen, W., Xi, W., Ding, Q., Kieffer, N., Caen, J.P., Chen, S., Chen, Z. & Xi, X. (2010) PML/RARalpha fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association. Proceedings of the National Academy of Sciences of the United States of America, 107, 37163721.
  • Yanada, M., Matsushita, T., Asou, N., Kishimoto, Y., Tsuzuki, M., Maeda, Y., Horikawa, K., Okada, M., Ohtake, S., Yagasaki, F., Matsumoto, T., Kimura, Y., Shinagawa, K., Iwanaga, M., Miyazaki, Y., Ohno, R. & Naoe, T. (2007) Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. European Journal of Haematology, 78, 213219.
  • Zhang, X.H., Hu, Y., Bao, L., Jiang, Q., Yang, L.H., Lu, X.J., Hong, M., Xia, L.H., Guo, T., Shen, G.X., Zhu, H.H., Zhao, T. & Song, S.J. (2009) Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia. Chinese Medical Journal, 122, 19691973.
  • Zhao, W., Wang, H., Wang, X., Wu, F., Guo, W., Qu, B., Shen, Z. & Wang, Z. (2001) Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia. Thrombosis Research, 102, 197204.
  • Zhu, J., Guo, W.M., Yao, Y.Y., Zhao, W.L., Pan, L., Cai, X., Ju, B., Sun, G.L., Wang, H.L., Chen, S.J., Chen, G.Q., Caen, J., Chen, Z. & Wang, Z.Y. (1999) Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia, 13, 10621070.
  • Zver, S., Andoljsek, D. & Cernelc, P. (2004) Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. European Journal of Haematology, 72, 455456.